Previous close | 9.96 |
Open | 11.19 |
Bid | 10.57 x 800 |
Ask | 11.36 x 900 |
Day's range | 10.13 - 11.19 |
52-week range | 8.73 - 17.02 |
Volume | |
Avg. volume | 284,622 |
Market cap | 954.226M |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 24.22 |
EPS (TTM) | 0.44 |
Earnings date | 24 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.40 |
NOVA LIMA, Brazil, March 24, 2023--Afya Limited, or Afya (Nasdaq: AFYA), today announced that, after the completion of its third share repurchase program, which resulted in the purchase of 1,874,457 Class A common shares, its Board of Directors has approved a new share repurchase program providing for the repurchase of up to 2,000,000 of its outstanding Class A common shares (the "Shares"), which represents approximately 5.8% of its free float in accordance with the conditions established by the
Afya (AFYA) delivered earnings and revenue surprises of -16.13% and 4.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NOVA LIMA, Brazil, March 22, 2023--Afya Limited (Nasdaq: AFYA) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the fourth quarter and full-year period ended December 31, 2022. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).